Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Notably, its total sales reached $7.132 billion in 2023, with projections placing Trulicity as the top diabetes drug in 2024, potentially outperforming competitors like Novo Nordisks Ozempic (semaglutide) and AstraZenecas Farxiga (dapagliflozin)
For example, GHK-Cu is studied
It also supports mitochondrial flexibility and drives the one-carbon metabolism cycle, making it a cornerstone of metabolic health, epigenetic regulation, and longevity
In dollar terms, the math works out to a gross cost per member of $8.99 in 2021 rising to $23.16 in 2023H1
US$ 29.69
US$ 24.27
US$ 20.85
US$ 23.80
